A Study of Eloralintide (LY3841136) in Healthy Participants

NCT07701083 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Eloralintide

Sponsor

Eli Lilly and Company